EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs

Sara Bizzotto, Maya Talukdar iD, Edward A Stronge, Rosita B Ramirez, Yingxi Yang, August Yue Huang iD, Qiwen Hu, Yingping Hou, Norma K Hylton, Benjamin Finander, Ashton Tillett, Zinan Zhou und 13 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2509622122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Sara Bizzotto und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics and Genomics, Manton Center for Orphan Disease Research, Boston, MA 02115. Hauptthemen laut MEDLINE: Transcriptome, Focal Cortical Dysplasia, Epilepsy, Cerebral Cortex. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While it is widely accepted that somatic variants that activate the PI3K-mTOR pathway are a major cause of drug-resistant focal epilepsy, typically associated with focal cortical dysplasia (FCD) type 2, understanding the mechanism of epileptogenesis requires identifying genotype-associated changes at the single-cell level, which is technically challenging with existing methods. Here, we performed single-nucleus RNA-sequencing (snRNA-seq) of 18 FCD type 2 samples removed surgically for treatment of drug-resistant epilepsy, and 17 non-FCD control samples, and analyzed additional published data comprising >400,000 single nuclei. We also performed simultaneous single-nucleus genotyping and gene expression analysis using two independent approaches: 1) a method that we called genotyping of transcriptomes enhanced with nanopore sequencing (GO-TEN) that combines targeted cDNA long-read sequencing with snRNA-seq, 2) ResolveOME snRNA-seq and DNA genotyping. snRNA-seq showed similar cell identities and proportions between cases and controls, suggesting that mosaic pathogenic variants in PI3K-mTOR pathway genes in FCD exert their effect by disrupting transcription in conserved cell types. GO-TEN and ResolveOME analyses confirmed that pathogenic variant-carrying cells have well-differentiated neuronal or glial identities, with enrichment of variants in cells of the neuroectodermal lineage, pointing to cortical neural progenitors as possible loci of somatic mutation. Within FCD type 2 lesions, we identified upregulation of PI3K-mTOR signaling and related pathways in variant-carrying neurons, downregulation of these pathways in non-variant-carrying neurons, as well as associated changes in microglial activation, cellular metabolism, synaptic homeostasis, and neuronal connectivity, all potentially contributing to epileptogenesis. These genotype-specific changes in mosaic lesions highlight potential disease mechanisms and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TranscriptomeFocal Cortical DysplasiaEpilepsyCerebral CortexMalformations of Cortical Development, Group IHumansCase-Control StudiesGenotyping TechniquesSequence AnalysisSingle-Cell AnalysisMosaicismPhosphatidylinositol 3-KinaseTOR Serine-Threonine KinasesSignal TransductionMaleFemaleAdolescentAdultNeurons

Stichwörter der Autor:innen

MTORcerebral cortexdevelopmentepilepsysomatic mutation

Substanzen

Phosphatidylinositol 3-KinaseTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Division of Genetics and Genomics, Manton Center for Orphan Disease Research, Boston, MA 02115.
  • Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
  • Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
  • Imagine Institute, Team Somatic Mosaicism in Neurodevelopment and Disease, Université Paris Cité, Paris 75015, France.
  • Harvard/Massachusetts Institute of Technology MD-PhD Program, Harvard Medical School, Boston, MA 02115.
  • Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.

ORCID-Profile: Maya Talukdar, August Yue Huang, Michael S Hildebrand, Christopher A Walsh

Förderung

  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
  • NIA NIH HHS
  • NINDS NIH HHS
  • NIGMS NIH HHS
  • Howard Hughes Medical Institute (HHMI)
  • NICHD NIH HHS
  • HHS | National Institutes of Health (NIH)

Zitieren

APA

Bizzotto, S., Talukdar, M., Stronge, E. A., Ramirez, R. B., Yang, Y., Huang, A. Y., Hu, Q., Hou, Y., Hylton, N. K., Finander, B., Tillett, A., Zhou, Z., Chhouk, B. H., D'Gama, A. M., Yang, E., Green, T. E., Reutens, D. C., Mullen, S. A., Scheffer, I. E., …, & Walsh, C. A. (2025). Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2509622122

Vancouver

Bizzotto S, Talukdar M, Stronge EA, Ramirez RB, Yang Y, Huang AY, et al. Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2509622122

BibTeX
@article{Bizzotto2025,
  author = {Bizzotto, Sara and Talukdar, Maya and Stronge, Edward A and Ramirez, Rosita B and Yang, Yingxi and Huang, August Yue and Hu, Qiwen and Hou, Yingping and Hylton, Norma K and Finander, Benjamin and Tillett, Ashton and Zhou, Zinan and Chhouk, Brian H and D'Gama, Alissa M and Yang, Edward and Green, Timothy E and Reutens, David C and Mullen, Saul A and Scheffer, Ingrid E and Hildebrand, Michael S and Buono, Russell J and Blümcke, Ingmar and Poduri, Annapurna H and Khoshkhoo, Sattar and Walsh, Christopher A},
  title = {Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2509622122}
}
Kostenlos starten →